Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

In vivo characterization of CYP2D612, 29 and *84 using dextromethorphan as a probe drug: a case report

[Distinguishing CYP2D6 Homozygous and Heterozygous Extensive Metabolizers by Dextromethorphan Phenotyping].

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D617 and CYP2D629, When Compared with Normal Metabolizers

A Familial Study of Cytochrome P450 2D6(CYP2D6) Deficient Alleles

DETERMINATION OF CYP2D6 ACTIVITY BY CAPILLARY GAS CHROMATOGRAPHY AND ITS APPLICATION IN METABOLIC PHENOTYPING

The Cytochrome P450 2D6 (CYP2D6) Enzyme Polymorphism: Screening Costs and Influence on Clinical Outcomes in Psychiatry

Dextromethorphan Metabolic Phenotyping in a Chinese Population

Frequency of CYP2D610 and 14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

Correlation of Genetic Polymorphism of Cytochrome P4502D6 with Dextromethorphan Oxidative Metabolism in Chinese.

Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Correlation Between Cytochrome P-450cyp2d6 Cyp2d6) Genotype and Phenotype

Functional Characterization of Cyp2d6 Novel Allelic Variants Identified in the Chinese Han Population

Genotyping of cytochrome P450 2D6 enzyme deficient alleles CYP2D6A and CYP2D6B by one-step ASA analysis

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping

Identification And Functional Characterization Of New Potentially Defective Alleles Of Human Cyp2c19

Prediction and visualization of CYP2D6 genotype-based phenotype using clustering algorithms

In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report